Autism Therapy: antagonist

A new class of drug (mGluR5 antagonist) may help the brains of people with autism to work better.

This review article describes Fragile X Syndrome and relates therapies for Fragile X Syndrome to therapies for autism. Both Fragile X Syndrome and autism result from brain problems involving the connection between different parts of the brain. The authors believe that this can be caused by too much protein in the brain. They believe that mGluR5 antagonists may help by decreasing the amount of protein in the brain of people with autism. This drug has not yet been tested in people.